Pharmacom Biovet IncOver The Counter Market:PHMB
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pharmacom Biovet Inc | 860.0 | 0.0x | --- |
Pazoo Inc | 2.7K | --- | --- |
Accelera Innovations Inc | 80.0 | 0.0x | --- |
Bitcoin Generation Inc | 25.4K | 0.0x | --- |
Capital Group Holdings Inc | 90.0 | 0.0x | --- |
American Health Protection Corp | 18.5K | 0.0x | --- |
Company Information
PharmaCom BioVet Inc., formerly ABV Gold Inc., intends to introduce and further develop bone marrow transplantation and other cancer treatment procedures to benefit companion animals (canine and feline) that are diagnosed with lymphoma, other types of cancers and other diseases. The Company is introducing canine bone marrow transplantation. ABV Gold Inc. was a gold and precious metals mining company founded as an exploration company to locate, explore and mine deposits. The Company holds claims in three different properties: The Toiyabe Uranium, the Parin Mining, and the Dun Glen properties.
Contact Information
- Headquarters
- 6040-A Six Forks Road, Suite 135RALEIGH, NC, United States 27609
- Phone
- 919-604-4887
- Fax
- 919-846-9225
Executives
- President
- Daniel Ryan
- Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
- Peter Preston
- President of Plan B Productions of Utah, Inc, Director
- Russell Heaton
- Director
- Enzo Vettese
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $860.00 |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 856.1M |
Pharmacom Biovet Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.99 |
Book Value | $0.19 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
